Kim Theilgaard-Mønch

Kim Theilgaard-Mønch

Clinical Associate Professor, Group leader

Member of:

    ORCID: 0000-0002-4239-4939

    Publication year:
    All
    1 - 6 out of 6Page size: 10
    1. 2022
    2. Published

      Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study

      Kristensen, D. T., Nielsen, L. B., Jakobsen, L. H. K., Kristensen, T. C., Jepsen, L. Ø., Schöllkopf, C., Theilgaard-Mønch, Kim, El-Galaly, T. C., Roug, A. S. & Severinsen, M. T., 2022, In: British Journal of Haematology. 199, p. 539-548 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Inhibition of oxidized nucleotide sanitation by TH1579 and conventional chemotherapy cooperatively enhance oxidative DNA-damage and survival in AML

      Centio, A., Estruch Alrich, Montserrat, Reckzeh, K., Sanjiv, K., Vittori, Camilla, Engelhard, Sophia Manon Charlotte, Warpman Berglund, U., Helleday, T. & Theilgaard-Mønch, Kim, 2022, In: Molecular Cancer Therapeutics. p. 703-714

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Phosphorylation of SHP2 at Tyr62 enables acquired resistance to SHP2 allosteric inhibitors in FLT3-ITD-driven AML

      Pfeiffer, A., Franciosa, Giulia, Locard-Paulet, Marie, Piga, I., Reckzeh, K., Vemulapalli, V., Blacklow, S. C., Theilgaard-Mønch, Kim, Jensen, Lars Juhl & Olsen, Jesper Velgaard, 2022, In: Cancer Research. 82, 11, p. 2141-2155 15 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients

      Jensen, O., Øvlisen, A. K., Jakobsen, L. H., Roug, A. S., Nielsen, R. E., Marcher, C. W., Ebbesen, L. H., Theilgaard-Mønch, Kim, Møller, P., Schöllkopf, C., Torp-Pedersen, Christian, El-Galaly, T. C. & Severinsen, M. T., 2022, In: Clinical Epidemiology. 14, p. 225-237 13 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event

      Reckzeh, K., Estruch Alrich, Montserrat, Ali, M., Helbo, A. S., Mosbech, A., Won, K. J., Rücker, F., Döhner, K. & Theilgaard-Mønch, Kim, 2022, In: British Journal of Haematology. 197, 2, p. 201-206

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation: In memoriam Professor Niels Borregaard

      Theilgaard-Mønch, Kim, Pundhir, Sachin, Reckzeh, K., Su, Jinyu, Tapia, Marta Cecylia, Furtwängler, Benjamin, Jendholm, J., Jakobsen, J. S., Hasemann, M. S., Knudsen, K. J., Cowland, J. B., Fossum, A., Schoof, E., Schuster, Mikkel Bruhn & Porse, Bo Torben, 2022, In: Nature Communications. 13, 1, 17 p., 3595.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 3997971